Journal of addiction medicine (J Addict Med)

Journal PubWeight™ 373.19‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 A systematic review of community opioid overdose prevention and naloxone distribution programs. 2014 2.61
2 Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. 2015 2.38
3 Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. 2010 2.19
4 An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. 2011 2.06
5 Factors affecting noncompliance with buprenorphine maintenance treatment. 2014 2.06
6 American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015 2.03
7 Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis Users. 2015 2.03
8 The Prevalence of Substance Use and Other Mental Health Concerns Among American Attorneys. 2016 1.95
9 Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. 2010 1.93
10 Things that Work, Things that Don't Work, and Things that Matter-Including Words. 2015 1.91
11 Adoption and implementation of medications in addiction treatment programs. 2011 1.89
12 The first three years of buprenorphine in the United States: experience to date and future directions. 2007 1.83
13 Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. 2015 1.80
14 Food addiction: an examination of the diagnostic criteria for dependence. 2009 1.66
15 Methadone dose, take home status, and hospital admission among methadone maintenance patients. 2012 1.53
16 How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 2011 1.49
17 A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. 2013 1.47
18 Psychiatrist characteristics that influence use of buprenorphine medication-assisted treatment. 2010 1.47
19 Buprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico. 2007 1.47
20 A novel community-based buprenorphine program: client description and initial outcomes. 2014 1.42
21 Gender differences in adolescent marijuana use and associated psychosocial characteristics. 2011 1.42
22 Assessment of source and type of alcohol consumed by high school students: analyses from four States. 2009 1.41
23 Methadone-related overdose deaths in rural Virginia: 1997 to 2003. 2013 1.40
24 Statistics Failures Make Lawyer Addiction Estimates Worthless. 2016 1.39
25 Sources of Prescription Opioids for Nonmedical Use. 2016 1.39
26 Stigmatizing and Misleading Terminology-More. 2016 1.38
27 Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. 2011 1.38
28 Energy drinks, soft drinks, and substance use among United States secondary school students. 2014 1.36
29 The case for chronic disease management for addiction. 2008 1.36
30 Concerns about pregabalin: further experience with its potential of causing addictive behaviors. 2013 1.28
31 Impulsive sensation seeking, parental history of alcohol problems, and current alcohol and tobacco use in adolescents. 2008 1.28
32 The role of the CHRNA4 gene in Internet addiction: a case-control study. 2012 1.22
33 Knowledge, Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women. 2015 1.18
34 Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. 2008 1.18
35 Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. 2012 1.16
36 Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. 2010 1.15
37 The Opioid dependent mother and newborn dyad: non-pharmacologic care. 2008 1.14
38 Premature deaths after discharge from methadone maintenance: a replication. 2007 1.14
39 Imaging of brain dopamine pathways: implications for understanding obesity. 2009 1.14
40 Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). 2009 1.13
41 Buprenorphine: the basic pharmacology revisited. 2007 1.13
42 Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry. 2013 1.11
43 A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. 2013 1.11
44 The effect of methadone dose regimen on neonatal abstinence syndrome. 2015 1.11
45 Science and electronic cigarettes: current data, future needs. 2014 1.11
46 Internet highs--seizures after consumption of synthetic cannabinoids purchased online. 2012 1.11
47 Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. 2011 1.10
48 Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment Study. 2008 1.08
49 Cocaine use and buprenorphine compliance. 2015 1.07
50 Methadone and buprenorphine during pregnancy. 2015 1.07
Next 50